
Two-Day Conference Addresses Topic of Measuring Ethicality
Can ethics be measured? Can data offer a better understanding of the ethicality of clinical research?
Those are the questions being presented Thursday, Feb. 21, and Friday, Feb. 22, at a conference titled "Empirical Bioethics: Emerging Trends for the 2st Century. The event takes place in the Kingsgate Marriott Conference Center on UCs medical campus. Registration is required by Feb. 15, 2013.
Sponsored by the Center for Clinical and Translational Science and Training (CCTST) and the Ethics Center at Cincinnati Childrens Hospital Medical Center, this conference will bring together local and national experts on the topic of bioethics to discuss cutting-edge research defining the ethical framework guiding clinical and translational studies.
Keynote speaker Daniel Sulmasy, MD, PhD, Kilbride-Clinton Professor of Medicine and Ethics and associate director of the MacLean Center for Clinical Medical Ethics at the University of Chicago, will present "Ethics and Evidence: What Data Can and Cannot Do for Bioethics.
Featured presenters on Day 2 are Peter Ubel, MD, professor, Fuqua School of Business and Sanford School of Public Policy, Duke University, and Rebecca Pentz, PhD, professor of research ethics with the Winship Cancer Institute, Emory University School of Medicine.
A sampling of additional presentation topics include:
Returning childrens genomic data research results to parents.
Vaccine decision aids.
Informed consent in pediatric cancer research.
Measuring voluntary consent in parents with seriously ill children.
Influences of financial interest disclosures in the informed consent process.
Community consultation in studies involving exception to informed consent.
"Medical science is moving into a new era, one in which important ethical issues faced by patients, clinicians and researchers are being scrutinized more closely than ever before, says Richard Ittenbach, PhD, professor of pediatrics at UC, member of the biostatistics and epidemiology division at Cincinnati Childrens, and member of the CCTST ethics group. "The processes used to solve these dilemmas and the decisions that result are now being investigated using rigorous analytical methods.
"Developing an ethical framework that includes established and well-recognized methods will provide clinicians and scientists with a much-needed guide to confront many of our most pressing ethical questions.
The fee for the conference is $100, which includes a reception for attendees (Day 1), meals (Day 2) and parking. Continuing medical education credits, psychology ethics credits, and social work values and ethics clock hours are available. Additional information and links to online registration can be found at www.cctst.uc.edu/node/195.
Questions should be directed to Bettie Durant at 513-803-2610 or bettie.durant@cchmc.org.
Tags
Related Stories
Growing heart failure epidemic calls for prioritizing primary...
May 5, 2025
A rapidly growing heart failure epidemic calls for prioritizing primary prevention, according to a new scientific statement from the American Heart Association published in Circulation in April. The statement reviews the current evidence for predicting heart failure risk and offers risk-based strategies for heart failure prevention.
Machine learning brings new insights to cell’s role in...
April 30, 2025
Researchers led by the University of Cincinnati’s Anna Kruyer and the University of Houston’s Demetrio Labate have published research in the journal Science Advances applying object recognition technology to track changes in brain cell structure and provide new insights into how the brain responds to heroin use, withdrawal and relapse.
Most teens prescribed SSRIs did not have recommended follow-up...
April 30, 2025
The University of Cincinnati and Cincinnati Children's Hospital Medical Center's Martine Lamy commented to Medscape on new research that found fewer than half of the adolescents prescribed a selective serotonin reuptake inhibitor (SSRI) at two large Chicago pediatric primary care clinics had a follow-up visit within the recommended 6 weeks.